Your browser doesn't support javascript.
loading
miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
Zhu, Chaonan; Wang, Shuai; Zheng, Maogen; Chen, Zhiquan; Wang, Guochen; Ma, Jun; Zhang, Bin; Huang, Wuhao; Sun, Xiaoyan; Wang, Changli.
Afiliación
  • Zhu C; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China.
  • Wang S; Department of Thoracic Surgery, North China University of Science and Technology Affiliated Hospital, 063000, Tangshan, China.
  • Zheng M; Department of Thoracic Surgery, North China University of Science and Technology Affiliated Hospital, 063000, Tangshan, China.
  • Chen Z; Department of Thoracic Surgery, North China University of Science and Technology Affiliated Hospital, 063000, Tangshan, China.
  • Wang G; Department of Thoracic Surgery, North China University of Science and Technology Affiliated Hospital, 063000, Tangshan, China.
  • Ma J; Department of Thoracic Surgery, Shanxi Provincial People's Hospital, 030012, Taiyuan, China.
  • Zhang B; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China.
  • Huang W; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China.
  • Sun X; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China.
  • Wang C; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, 300060, Tianjin, China. wangchangli@tjmuch.co
Strahlenther Onkol ; 198(3): 304-314, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35037949
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / MicroARNs / Tensinas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / MicroARNs / Tensinas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Strahlenther Onkol Asunto de la revista: NEOPLASIAS / RADIOTERAPIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania